ZAGATTI, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 1.885
EU - Europa 586
AS - Asia 369
Totale 2.840
Nazione #
US - Stati Uniti d'America 1.885
CN - Cina 182
PL - Polonia 142
IT - Italia 123
UA - Ucraina 86
TR - Turchia 81
DE - Germania 63
SG - Singapore 59
SE - Svezia 58
GB - Regno Unito 52
FI - Finlandia 24
ID - Indonesia 23
RO - Romania 19
VN - Vietnam 11
FR - Francia 7
BE - Belgio 6
HK - Hong Kong 5
IR - Iran 4
IN - India 3
CZ - Repubblica Ceca 1
GR - Grecia 1
HR - Croazia 1
IE - Irlanda 1
NL - Olanda 1
NO - Norvegia 1
UZ - Uzbekistan 1
Totale 2.840
Città #
Fairfield 290
Houston 195
Woodbridge 193
Chandler 148
Warsaw 142
Ann Arbor 132
Ashburn 126
Seattle 112
Jacksonville 108
Wilmington 101
Cambridge 88
Ferrara 59
Izmir 49
Beijing 46
Singapore 39
Nanjing 35
Milan 28
Princeton 25
Shanghai 25
New York 24
Jakarta 22
Boardman 20
Los Angeles 18
San Diego 18
Timisoara 17
Nanchang 13
Bremen 11
Falls Church 11
Santa Clara 11
Shenyang 10
Changsha 9
Dong Ket 9
Addison 8
Hebei 8
Dearborn 7
London 7
Brussels 6
Jiaxing 6
Augusta 5
Mountain View 5
Orange 5
Tianjin 5
Auburn Hills 4
Guangzhou 4
Hong Kong 4
Ningbo 4
Washington 4
Ardabil 3
Bologna 3
Castelmassa 3
Des Moines 3
Kunming 3
Leawood 3
Munich 3
Norwalk 3
Philadelphia 3
Tappahannock 3
Zhengzhou 3
Changchun 2
Focsani 2
Hangzhou 2
Hanoi 2
Helsinki 2
Jinan 2
Monmouth Junction 2
Monte San Pietro 2
Redwood City 2
Salò 2
San Giorgio Di Piano 2
San Mateo 2
Brentwood 1
Brno 1
Chicago 1
Costabissara 1
Dublin 1
Edinburgh 1
Hefei 1
Hounslow 1
Imola 1
Kilburn 1
McDonough 1
Pasadena 1
Pavullo Nel Frignano 1
Pune 1
Redmond 1
Rome 1
Salt Lake City 1
San Francisco 1
San Jose 1
Taglio Di Po 1
Taizhou 1
Trieste 1
Ulm 1
Verona 1
Zagreb 1
Totale 2.298
Nome #
Absolute quantification of cell-free microRNAs in cancer patients 182
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 175
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 149
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 148
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 141
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 139
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 133
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 133
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 127
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 122
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 118
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 113
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 109
null 109
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 108
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 108
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 102
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 97
null 89
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 81
EPIGENETIC CHANGES AT CHROMOSOME REGION 11p15.5 IN HUMAN CANCER 79
null 77
MicroRNA expression profile in peripheral blood cells of psoriatic arthritis 75
KVDMR1, A LOCUS FREQUENTLY HYPOMETHYLATED IN HUMAN CANCER, IS A STRONG ENHANCER-PROMOTER ELEMENT FOR THE EXPRESSION OF LIT1, AN UNTRANSLATED IMPRINTOR GENE AT CHROMOSOME 11p15.5. 64
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 58
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 30
Altered miRNA expression in T regulatory cells in course of multiple sclerosis 24
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 21
Totale 2.911
Categoria #
all - tutte 12.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.255


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020456 0 0 0 89 45 66 47 52 53 53 24 27
2020/2021599 44 58 40 50 41 60 26 52 12 98 66 52
2021/2022347 13 30 35 14 23 16 23 26 6 23 41 97
2022/2023311 30 35 5 54 39 48 26 21 37 1 6 9
2023/2024198 15 24 9 3 15 42 11 12 5 13 0 49
2024/202592 17 15 59 1 0 0 0 0 0 0 0 0
Totale 2.911